---
title: "Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP | LNAI Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285080781.md"
description: "Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP | LNAI Stock News"
datetime: "2026-05-04T05:35:33.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285080781.md)
  - [en](https://longbridge.com/en/news/285080781.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285080781.md)
---

# Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP | LNAI Stock News

Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP | LNAI Stock News

### Related Stocks

- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [RENB.US](https://longbridge.com/en/quote/RENB.US.md)

## Related News & Research

- [MATTHEWS INTERNATIONAL ANNOUNCES PARTIAL REDEMPTION OF PREFERRED EQUITY INTEREST IN PROPELIS | MATW Stock News](https://longbridge.com/en/news/286961157.md)
- [15:31 ETRenowned IP Trial Lawyer Joins Latham & Watkins in Bay Area](https://longbridge.com/en/news/286957828.md)
- [Liberty Broadband Corporation Declares Quarterly Cash Dividend on Series A Cumulative Redeemable Preferred Stock | LBRDA Stock News](https://longbridge.com/en/news/286621148.md)
- [LG CNS Expands North American AX Business, Supporting Smart Factory Transformation for SMEs](https://longbridge.com/en/news/286971453.md)
- [06:57 ETMETiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026](https://longbridge.com/en/news/287051942.md)